Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
162.16B | 166.30B | 153.98B | 135.50B | 134.00B | 193.32B | Gross Profit |
16.97B | 15.78B | 13.60B | 17.34B | 12.67B | 20.59B | EBIT |
3.77B | 3.15B | 185.00M | 4.24B | -595.00M | 3.71B | EBITDA |
10.42B | 12.00B | 6.46B | 9.89B | -3.27B | 12.37B | Net Income Common Stockholders |
5.21B | 3.45B | 960.00M | 4.15B | -11.91B | 24.86B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
27.55B | 26.95B | 25.50B | 30.30B | 29.59B | 32.69B | Total Assets |
164.12B | 150.47B | 141.30B | 139.67B | 132.63B | 148.96B | Total Debt |
67.25B | 49.49B | 49.93B | 50.27B | 49.09B | 54.19B | Net Debt |
50.50B | 22.55B | 24.43B | 19.96B | 19.50B | 21.51B | Total Liabilities |
115.03B | 90.01B | 91.01B | 90.77B | 89.98B | 95.08B | Stockholders Equity |
44.03B | 52.40B | 43.38B | 42.59B | 37.26B | 48.42B |
Cash Flow | Free Cash Flow | ||||
-1.32B | 3.42B | -2.89B | 458.00M | 2.02B | -10.03B | Operating Cash Flow |
4.75B | 7.62B | 4.65B | 5.47B | 5.59B | -280.00M | Investing Cash Flow |
5.77B | -3.52B | -6.43B | -2.24B | -2.74B | -2.03B | Financing Cash Flow |
-18.73B | -1.92B | -1.74B | -1.15B | -4.98B | 16.00B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $1.91T | 5.71 | 12.64% | 3.96% | 6.27% | 19.66% | |
74 Outperform | $3.47T | 8.21 | 15.02% | 2.41% | 14.46% | 62.35% | |
71 Outperform | $6.78T | 7.86 | 6.54% | 4.62% | 12.25% | 15.01% | |
64 Neutral | $26.32B | 95.82 | -0.14% | ― | -2.35% | ― | |
61 Neutral | $6.97B | 11.38 | 2.88% | 3.90% | 2.64% | -22.07% | |
57 Neutral | ¥50.94B | 7.78 | 4.71% | -12.06% | -30.83% | ||
45 Neutral | ¥278.52B | ― | -77.14% | ― | 11.94% | -1374.36% |